| Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials PE Sax, KM Erlandson, JE Lake, GA Mccomsey, C Orkin, S Esser, ... Clinical Infectious Diseases 71 (6), 1379-1389, 2020 | 719 | 2020 |
| Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz … GA McComsey, D Kitch, ES Daar, C Tierney, NC Jahed, P Tebas, L Myers, ... Journal of Infectious Diseases 203 (12), 1791-1801, 2011 | 610 | 2011 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 588 | 2023 |
| Bone disease in HIV infection: a practical review and recommendations for HIV care providers GA McComsey, P Tebas, E Shane, MT Yin, ET Overton, JS Huang, ... Clinical infectious diseases 51 (8), 937-946, 2010 | 504 | 2010 |
| Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen TT Brown, GA McComsey, MS King, RB Qaqish, BM Bernstein, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (5), 554-561, 2009 | 368 | 2009 |
| Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells MM Lederman, L Calabrese, NT Funderburg, B Clagett, K Medvik, ... Journal of Infectious Diseases 204 (8), 1217-1226, 2011 | 367 | 2011 |
| Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor–sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized … JL Lennox, RJ Landovitz, HJ Ribaudo, I Ofotokun, LH Na, C Godfrey, ... Annals of internal medicine 161 (7), 461-471, 2014 | 316 | 2014 |
| Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy AC Ross, N Rizk, MA O'Riordan, V Dogra, D El-Bejjani, N Storer, D Harrill, ... Clinical Infectious Diseases 49 (7), 1119-1127, 2009 | 311 | 2009 |
| Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy TT Brown, K Tassiopoulos, RJ Bosch, C Shikuma, GA McComsey Diabetes care 33 (10), 2244-2249, 2010 | 289 | 2010 |
| Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D TT Brown, GA McComsey Antiviral therapy 15 (3), 425-429, 2010 | 228 | 2010 |
| Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy DA Wohl, G McComsey, P Tebas, TT Brown, MJ Glesby, D Reeds, ... Clinical Infectious Diseases 43 (5), 645-653, 2006 | 218 | 2006 |
| Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus—infected patients switched from stavudine to abacavir or … GA McComsey, DJ Ward, SM Hessenthaler, MG Sension, P Shalit, ... Clinical infectious diseases 38 (2), 263-270, 2004 | 218 | 2004 |
| Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine GA McComsey, DM Paulsen, JT Lonergan, SM Hessenthaler, CL Hoppel, ... Aids 19 (1), 15-23, 2005 | 210 | 2005 |
| Weight gain and integrase inhibitors AR Eckard, GA McComsey Current opinion in infectious diseases 33 (1), 10-19, 2020 | 209 | 2020 |
| Risk factors for weight gain following switch to integrase inhibitor–based antiretroviral therapy JE Lake, K Wu, SH Bares, P Debroy, C Godfrey, JR Koethe, ... Clinical Infectious Diseases 71 (9), e471-e477, 2020 | 201 | 2020 |
| Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995–1999 H Valdez, TK Chowdhry, R Asaad, IJ Woolley, T Davis, R Davidson, ... Clinical infectious diseases 32 (10), 1487-1493, 2001 | 192 | 2001 |
| Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV GA McComsey, MA Kendall, P Tebas, S Swindells, E Hogg, ... Aids 21 (18), 2473-2482, 2007 | 187 | 2007 |
| Body composition changes after initiation of raltegravir or protease inhibitors: ACTG A5260s GA McComsey, C Moser, J Currier, HJ Ribaudo, P Paczuski, MP Dubé, ... Clinical Infectious Diseases 62 (7), 853-862, 2016 | 181 | 2016 |
| Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy NT Funderburg, Y Jiang, SM Debanne, D Labbato, S Juchnowski, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (4), 396-404, 2015 | 179 | 2015 |
| Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy NT Funderburg, Y Jiang, SM Debanne, N Storer, D Labbato, B Clagett, ... Clinical Infectious Diseases 58 (4), 588-595, 2014 | 166 | 2014 |
